337 studies found for:
Open Studies | "Stomach Neoplasms"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Recruiting |
S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric Carcinoma
|
||||
| 22 | Recruiting |
A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients
|
||||
| 23 | Recruiting |
Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer
|
||||
| 24 | Recruiting |
Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer
|
||||
| 25 | Recruiting |
Study of Adjuvant Radiochemotherapy for Gastric Cancer
|
||||
| 26 | Unknown † |
Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer
|
||||
| 27 | Unknown † |
Docetaxel and Epirubicin in Advanced Gastric Cancer
|
||||
| 28 | Recruiting |
Botulinum Toxin for Stomach Cancer Treatment
|
||||
| 29 | Unknown † |
Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer
|
||||
| 30 | Recruiting |
Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer
|
||||
| 31 | Recruiting |
The Gastric Cancer Foundation: A Gastric Cancer Registry
|
||||
| 32 | Recruiting |
Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer
|
||||
| 33 | Recruiting |
RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression
|
||||
| 34 | Unknown † |
Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer
|
||||
| 35 | Not yet recruiting |
XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer
|
||||
| 36 | Recruiting |
Early Onset and Familial Gastric Cancer Registry
|
||||
| 37 | Recruiting |
XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer
|
||||
| 38 | Recruiting |
A Phase 3 Study to Compare Efficacy and Safety of DHP107 Versus Taxol® in Patients With Metastatic or Recurrent Gastric Cancer After Failure of First-line Chemotherapy
|
||||
| 39 | Recruiting |
A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
|
||||
| 40 | Recruiting |
Compliance to ERAS After Gastric Surgery
|
† Indicates status has not been verified in more than two years

